1. Spring harvest? Reflections on the rise of type 1 diabetes

   • E. A. M. Gale

   Editorial 10 November 2005 Pages: 2445 - 2450

   

2. Fine-tuning insulin and nitric oxide signalling by turning up the AMPs: new insights into AMP-activated protein kinase signalling

   • Y. C. Long
   • J. R. Zierath

   Commentary 11 November 2005 Pages: 2451 - 2453

   

3. Contraindications can damage your health—is metformin a case in point?

   • A. Holstein
   • M. Stumvoll

   For debate 11 November 2005 Pages: 2454 - 2459

4. Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies

   • T. Cukierman
   • H. C. Gerstein
   • J. D. Williamson

   Review 08 November 2005 Pages: 2460 - 2469

   

5. Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects

   • M. Walker
   • A. Mari
   • E. Ferrannini

   Article 01 November 2005 Pages: 2470 - 2476

   

6. Long-term effects on lipids and lipoproteins of pioglitazone versus gliclazide addition to metformin and pioglitazone versus metformin addition to sulphonylurea in the treatment of type 2 diabetes

   • D. J. Betteridge
   • B. Vergès

   Short Communication 10 November 2005 Pages: 2477 - 2481

   

7. Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS)

   • H. M. Colhoun
   • D. J. Betteridge
   • on behalf of the CARDS Investigators

   Short Communication 12 November 2005 Pages: 2482 - 2485

   

8. Renal hyperfiltration in type 2 diabetes: effect of age-related decline in glomerular filtration rate

   • E. Premaratne
   • R. J. MacIsaac
   • G. Jerums

   Article 01 November 2005 Pages: 2486 - 2493

   

9. Visual fields correlate better than visual acuity to severity of diabetic retinopathy

   • B. Bengtsson
   • A. Heijl
   • E. Agardh

   Article 01 November 2005 Pages: 2494 - 2500

   

10. The ‘accelerator hypothesis’: relationship between weight, height, body mass index and age at diagnosis in a large cohort of 9,248 German and Austrian children with type 1 diabetes mellitus

    • I. Knerr
    • J. Wolf
    • on behalf of the DPV Scientific Initiative of Germany and Austria

    Short Communication 11 November 2005 Pages: 2501 - 2504

    

11. Early growth and type 2 diabetes: evidence from the 1946 British birth cohort

    • M. Wadsworth
    • S. Butterworth
    • R. Hardy

    OriginalPaper 11 November 2005 Pages: 2505 - 2510

    

12. The impact of ethnicity and sex on subclinical cardiovascular disease: the Diabetes Heart Study

    • B. I. Freedman
    • F. C. Hsu
    • L. E. Wagenknecht

    Article 01 November 2005 Pages: 2511 - 2518

13. Myocardial infarction in diabetic and non-diabetic persons with and without prior myocardial infarction: the FINAMI Study

    • P. Pajunen
    • H. Koukkunen
    • V. Salomaa

    Article 25 October 2005 Pages: 2519 - 2524

    

14. Weight gain in relation to plasma levels of complement factor 3: results from a population-based cohort study

    • G. Engström
    • B. Hedblad
    • F. Lindgärde

    Article 11 November 2005 Pages: 2525 - 2531

15. A prospective study of depression and mortality in patients with type 2 diabetes: the Fremantle Diabetes Study

    • D. G. Bruce
    • W. A. Davis
    • T. M. E. Davis

    Article Paper 15 November 2005 Pages: 2532 - 2539

    

16. D6S265*15 marks a DRB1*15, DQB1*0602 haplotype associated with attenuated protection from type 1 diabetes mellitus

    • A. M. Valdes
    • G. Thomson
    • Swedish Childhood Study Group, Diabetes Incidence in Sweden Study Group, Type 1 Diabetes Component of the 13th International Histocompatibility Working Group

    Short Communication 18 November 2005 Pages: 2540 - 2543

    

17. Association of the E23K polymorphism in the KCNJ11 gene with gestational diabetes mellitus

    • N. Shaat
    • M. Ekelund
    • L. Groop

    Article 17 November 2005 Pages: 2544 - 2551

    

18. Primary and immortalised human pancreatic islet endothelial cells: phenotypic and immunological characterisation

    • E. Favaro
    • A. Bottelli
    • M. M. Zanone

    Article 15 November 2005 Pages: 2552 - 2562

    

19. Selective loss of glucose-induced amplification of insulin secretion in mouse pancreatic islets pretreated with sulfonylurea in the absence of fuels

    • K. A. Urban
    • U. Panten

    Short Communication 11 November 2005 Pages: 2563 - 2566

    

20. Essential role of the imidazoline moiety in the insulinotropic effect but not the K_ATP channel-blocking effect of imidazolines; a comparison of the effects of efaroxan and its imidazole analogue, KU14R

    • C. Bleck
    • A. Wienbergen
    • I. Rustenbeck

    Article 11 November 2005 Pages: 2567 - 2575

    

21. The IA-2 interactome

    • Y. F. Hu
    • H. L. Zhang
    • A. L. Notkins

    Short Communication 05 November 2005 Pages: 2576 - 2581

    

22. Extracellular signal-regulated kinase is essential for interleukin-1-induced and nuclear factor κB-mediated gene expression in insulin-producing INS-1E cells

    • L. Larsen
    • J. Størling
    • T. Mandrup-Poulsen

    Article 11 November 2005 Pages: 2582 - 2590

    

23. Insulin signalling downstream of protein kinase B is potentiated by 5′AMP-activated protein kinase in rat hearts in vivo

    • S. L. Longnus
    • C. Ségalen
    • E. Van Obberghen

    Article 11 November 2005 Pages: 2591 - 2601

    

24. Effects of the nitric oxide donor, sodium nitroprusside, on resting leg glucose uptake in patients with type 2 diabetes

    • D. C. Henstridge
    • B. A. Kingwell
    • S. J. Duffy

    Article 05 November 2005 Pages: 2602 - 2608

    

25. Longitudinal changes in insulin sensitivity and secretion from birth to age three years in small- and appropriate-for-gestational-age children

    • V. Mericq
    • K. K. Ong
    • D. B. Dunger

    Article 08 November 2005 Pages: 2609 - 2614

    

26. Reduced intrahepatic fat content is associated with increased whole-body lipid oxidation in patients with type 1 diabetes

    • G. Perseghin
    • G. Lattuada
    • L. Luzi

    Article 01 November 2005 Pages: 2615 - 2621

    

27. Gene expression profiling in skeletal muscle of Zucker diabetic fatty rats: implications for a role of stearoyl-CoA desaturase 1 in insulin resistance

    • M. D. Voss
    • A. Beha
    • M. Korn

    Article 12 November 2005 Pages: 2622 - 2630

    

28. Dynamic strength training improves insulin sensitivity and functional balance between adrenergic alpha 2A and beta pathways in subcutaneous adipose tissue of obese subjects

    • J. Polak
    • C. Moro
    • M. Berlan

    Article 05 November 2005 Pages: 2631 - 2640

    

29. Adipokines and the insulin resistance syndrome in familial partial lipodystrophy caused by a mutation in lamin A/C

    • S. P. Y. Wong
    • M. Huda
    • J. H. Pinkney

    Article 17 November 2005 Pages: 2641 - 2649

    

30. Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli

    • N. A. Wahab
    • L. Schaefer
    • R. M. Mason

    Article 04 November 2005 Pages: 2650 - 2660

    

31. Fetal and neonatal exposure to nicotine in Wistar rats results in increased beta cell apoptosis at birth and postnatal endocrine and metabolic changes associated with type 2 diabetes

    • A. C. Holloway
    • G. E. Lim
    • H. C. Gerstein

    Article 04 November 2005 Pages: 2661 - 2666

    

32. Temporary hyperglycaemia provokes monocyte adhesion to endothelial cells in rat thoracic aorta

    • A. Otsuka
    • K. Azuma
    • H. Watada

    Original Paper 08 November 2005 Pages: 2667 - 2674

    

33. Increased expression of advanced glycation end-products and their receptor, and activation of nuclear factor kappa-B in lacrimal glands of diabetic rats

    • M. Alves
    • V. C. Calegari
    • E. M. Rocha

    Article 08 November 2005 Pages: 2675 - 2681

    

34. Mealtime inhaled insulin lowers fasting glucose: a look at possible explanations

    • J. H. DeVries

    Letter 05 November 2005 Pages: 2682 - 2683

35. Leptin : adiponectin ratio as an atherosclerotic index in patients with type 2 diabetes : relationship of the index to carotid intima–media thickness

    • K. Kotani
    • N. Sakane
    • Y. Kurozawa

    Reseach Letter 01 November 2005 Pages: 2684 - 2686

36. Comment on: McClung JA, Naseer N, Saleem M et al (2005) Circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA₁c. Diabetologia 48:345–350

    • A. Thanopoulou
    • B. Karamanos
    • A. Archimandritis

    Letter 05 November 2005 Pages: 2687 - 2687

37. Reply to comment on: McClung JA, Naseer N, Saleem M et al. (2005) Circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA₁c. Diabetologia 48:345–350

    • J. A. McClung
    • N. Naseer
    • A. Kappas

    Letter 25 October 2005 Pages: 2688 - 2688

38. Comment to: Grassi G, Dell’oro R, Quarti-Trevano F et al (2005) Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia 48:1359–1365

    • M. G. Clark

    Letter 04 November 2005 Pages: 2689 - 2690

39. A prospective study of lipoprotein(a) and risk of coronary heart disease among women with type 2 diabetes

    • I. Shai
    • M. B. Schulze
    • F. B. Hu

    Erratum 17 November 2005 Pages: 2691 - 2692

40. High glucose and hydrogen peroxide increase c-Myc and haeme-oxygenase 1 mRNA levels in rat pancreatic islets without activating NFκB

    • H. Elouil
    • A. K. Cardozo
    • J. C. Jonas

    Erratum 10 November 2005 Pages: 2693 - 2693

41. G.B. Morgagni Prizes 2006

    • Gaetano Crepaldi

    EASD News Section 06 February 2008 Pages: 2694 - 2701